← back to search

Gábor Kovács

University of Graz · AT
Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Chronic Obstructive Pulmonary Disease (COPD) Research, and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
h-index
55
citations
17,646
works
318
NIH funding
primary concept
Medicine
email

Recent publications

Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension
American Journal of Respiratory and Critical Care Medicine 2025cited by 9position: middledoi
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis
American Journal of Respiratory and Critical Care Medicine 2025cited by 8position: middledoi
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment
EBioMedicine 2025cited by 2position: middledoi
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era
Circulation 2024cited by 34position: middledoi
The ‘Ten Commandments’ of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Heart Journal 2023cited by 31position: middledoi
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Heart Journal 2022cited by 3,528position: middledoi
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Respiratory Journal 2022cited by 2,001position: middledoi
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances
American Journal of Respiratory and Critical Care Medicine 2021cited by 218position: middledoi
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
Genome Medicine 2021cited by 84position: middledoi
Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study
The Lancet Respiratory Medicine 2020cited by 268position: middledoi
Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial
European Heart Journal 2020cited by 121position: middledoi
Bayesian Inference Associates Rare <i>KDR</i> Variants With Specific Phenotypes in Pulmonary Arterial Hypertension
Circulation Genomic and Precision Medicine 2020cited by 46position: middledoi
Characterization of <i>GDF2</i> Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine 2019cited by 122position: middledoi
Hämodynamische Definition der pulmonalen Hypertonie: Kommentar zu der vorgeschlagenen Änderung durch das 6th World Symposium on Pulmonary Hypertension
DMW - Deutsche Medizinische Wochenschrift 2019cited by 15position: middledoi
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
Nature Communications 2018cited by 380position: middledoi
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
The Lancet Respiratory Medicine 2018cited by 210position: middledoi
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension
European Respiratory Journal 2018cited by 168position: middledoi
Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary Fibrosis
CHEST Journal 2018cited by 29position: middledoi
Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension
Circulation 2016cited by 664position: middledoi
Tobacco Smoke Exposure in Pulmonary Arterial and Thromboembolic Pulmonary Hypertension
Respiration 2014cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Horst Olschewski · Institut für Lungenforschung4 papers (2019–2025)Bradley A. Maron · University of Maryland, College Park3 papers (2020–2025)Tobias Lange · University of Regensburg2 papers (2014–2019)Marius M. Hoeper · Medizinische Hochschule Hannover2 papers (2019–2023)Silvia Ulrich · University of Zurich2 papers (2014–2025)Andrea Olschewski · University of Colorado Denver2 papers (2019–2025)Matthias Held · German Respiratory Society2 papers (2014–2019)Michael Halank · Städtisches Klinikum Dresden2 papers (2014–2019)Stephan Rosenkranz · Coastal Carolina Research Center2 papers (2019–2023)Marc Humbert · Médecins Sans Frontières2 papers (2020–2023)Daniel Dumitrescu · UCLA Medical Center1 papers (2019–2019)Gérald Simonneau · Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique1 papers (2020–2020)Harald Kaemmerer · Technical University of Munich1 papers (2019–2019)Eckhard Mayer · German Center for Lung Research1 papers (2019–2019)Karen M. Olsson · University Hospital Heidelberg1 papers (2019–2019)Hans‐Jürgen Seyfarth · University Hospital Leipzig1 papers (2014–2014)Ronald H. Goldstein · Boston University1 papers (2020–2020)Edward Hess · Colorado School of Public Health1 papers (2020–2020)Heinrike Wilkens · Universitätsklinikum des Saarlandes1 papers (2019–2019) · 1 papers (2020–2020)